Inventor · disambiguated record
Friedrich Scheiflinger
Also filed as: SCHEIFLINGER FRIEDRICH
76 granted patents·31 pending applications·465 citations·filing 1991–2025
99Inventor score
Top patents by PatentIndex Score
107 records- 0196US10800816B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted Oct 13, 2020·10 cites·25 claims
- 0295US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0394US8546096B2Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXIDOCKAL MICHAEL·Filed 2009·Granted Oct 1, 2013·14 cites·14 claims
- 0494US8450275B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2011·Granted May 28, 2013·13 cites·31 claims
- 0593US10201586B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2016·Granted Feb 12, 2019·10 cites·17 claims
- 0693US7884075B2Polymer-factor VIII-von Willebrand factor-conjugatesBAXTER INT·Filed 2005·Granted Feb 8, 2011·18 cites·85 claims
- 0792US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 0891US7501117B2Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER INNOVATIONS GMBH·Filed 2005·Granted Mar 10, 2009·12 cites·8 claims
- 0991US6926894B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER AG·Filed 2001·Granted Aug 9, 2005·39 cites·27 claims
- 1090US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 1190US6919311B2Factor VII polypeptide having factor VII:C activitySANQUIN BLOEDVOORZIENING·Filed 2001·Granted Jul 19, 2005·33 cites·8 claims
- 1289US8357779B2Polymer-von Willebrand factor-conjugatesBAXTER INT·Filed 2011·Granted Jan 22, 2013·9 cites·51 claims
- 1389US7575897B2Highly phosphorylated and sulfated recombinant factor IXBAXTER INT·Filed 2008·Granted Aug 18, 2009·10 cites·6 claims
- 1488US8466108B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2009·Granted Jun 18, 2013·10 cites·5 claims
- 1586US10822376B2Biologically active peptidesBAXALTA INC·Filed 2019·Granted Nov 3, 2020·1 cites·25 claims
- 1685US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 1784US8835388B2Polymer von Willebrand factor-conjugatesBAXTER INT·Filed 2012·Granted Sep 16, 2014·9 cites·20 claims
- 1883US7375084B2Highly phosphorylated and sulfated recombinant factor IXBAXTER INT·Filed 2007·Granted May 20, 2008·3 cites·6 claims
- 1982US11001613B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted May 11, 2021·1 cites·33 claims
- 2082US8022187B2FVIII-independent FIX-mutant proteins for hemophilia A treatmentBAXTER INT·Filed 2008·Granted Sep 20, 2011·4 cites·10 claims
- 2181US9018167B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Apr 28, 2015·3 cites·16 claims
- 2281US7297336B2Factor IXa specific antibodies displaying factor VIIIa like activityBAXTER INT·Filed 2003·Granted Nov 20, 2007·6 cites·13 claims
- 2380US8513386B2FVIII-independent FIX-mutant proteins for hemophilia a treatmentDOCKAL MICHAEL·Filed 2011·Granted Aug 20, 2013·3 cites·6 claims
- 2480US5670367ARecombinant fowlpox virusIMMUNO AG·Filed 1994·Granted Sep 23, 1997·53 cites·9 claims
- 2579US9447147B2Peptides and methods of useBAXTER INT·Filed 2015·Granted Sep 20, 2016·3 cites·9 claims
- 2678US9272021B2Treatment of coagulation disease by administration of recombinant VWFSCHEIFLINGER FRIEDRICH·Filed 2012·Granted Mar 1, 2016·6 cites·32 claims
- 2778US8962563B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Feb 24, 2015·3 cites·21 claims
- 2878US8822638B2Procoagulant peptidesSCHEIFLINGER FRIEDRICH·Filed 2011·Granted Sep 2, 2014·2 cites·16 claims
- 2978US8668909B2Anti MIF antibodiesKERSCHBAUMER RANDOLF·Filed 2010·Granted Mar 11, 2014·5 cites·17 claims
- 3078US8399249B2Procedure for the generation of a high producer cell line for the expression of a recombinant anti-CD34 antibodyKERSCHBAUMER RANDOLF·Filed 2009·Granted Mar 19, 2013·8 cites·6 claims
- 3178US6103244AMethods for generating immune responses employing modified vaccinia of fowlpox virusesBAXTER AG·Filed 1996·Granted Aug 15, 2000·36 cites·14 claims
- 3277US9465037B2Characterization of CHO-MIF gene and protein, and use thereofBaxalta GmbH·Filed 2012·Granted Oct 11, 2016·2 cites·29 claims
- 3376US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 3476US9556230B2TFPI inhibitors and methods of useBAXTER INT·Filed 2015·Granted Jan 31, 2017·1 cites·10 claims
- 3576US7910094B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER INNOVATIONS GMBH·Filed 2009·Granted Mar 22, 2011·0 cites·6 claims
- 3674US11793855B2TFPI inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 24, 2023·0 cites·22 claims
- 3774US9617523B2Nucleic acids encoding vitamin K expoxide reductase subunit 1 and vitamin K dependent protein expression and methods of using sameSCHEIFLINGER FRIEDRICH·Filed 2006·Granted Apr 11, 2017·2 cites·15 claims
- 3874US2022213172A1Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia aTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3973US11254731B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 4073US8133865B2von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkageBOSSARD MARY J·Filed 2007·Granted Mar 13, 2012·1 cites·27 claims
- 4173US7544660B2Factor VIII polypeptide having factor VIII:C activitySANQUIN BLOEDVOORZIENING·Filed 2004·Granted Jun 9, 2009·3 cites·7 claims
- 4273US5445953ADirect molecular cloning of a modified poxvirus genomeIMMUNO AG·Filed 1991·Granted Aug 29, 1995·41 cites·26 claims
- 4372US9873720B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2014·Granted Jan 23, 2018·1 cites·4 claims
- 4472US9777051B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2013·Granted Oct 3, 2017·1 cites·10 claims
- 4572US2023211017A1Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia aTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 4671US11124787B2ADAMTS13-containing compositions having thrombolytic activityTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 21, 2021·0 cites·17 claims
- 4771US2022002703A1Adamts13-containing compositions having thrombolytic activityTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 4870US11492388B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 4970US8703426B2Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLVLAEMMLE BERNHARD·Filed 2008·Granted Apr 22, 2014·0 cites·9 claims
- 5070US2024100128A1Gene therapy of hemophilia b using viral vectors encoding recombinant fix variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
Showing the top 50 of 107 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Friedrich Scheiflinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →